Bismutina
- Product NDC
- 53145-475
- 11-digit product format
- 531450475
- Labeler code
- 53145
- Product ID
- 53145-475_3a8b33c7-04b9-345d-e063-6294a90abba9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bismuth subsalicylate
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Menper Distributors, Inc.
- Application
- M024
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-04-01
- Substance
- BISMUTH SUBSALICYLATE
- Active strength
- 525 mg/30mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bismutina
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISMUTH SUBSALICYLATE | 525 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 62TEY51RR1 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308762 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53145-475-08 | 2023-07-28 | C162847 | 48780-1 | 0191ceaa-653d-198a-e063-dbdaa90aec3e | Bismutina |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-475-08 | Bismutina | 240 mL in 1 BOTTLE | LIQUID | 240 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SYNTHABIO Ivermectin | IVERMECTIN | Shenzhen Xuyan Technology Co., Ltd. | 540d6a24-68bf-50c8-e063-6294a90aaa30 | 2026-06-22 | Warnings | M024 |
| PINRID | PYRANTEL PAMOATE | YYBA CORP | 59da86a4-db0d-4551-9128-e09a4e85cd78 | 2026-05-25 | Warnings | M024 |
| PINRID | PYRANTEL PAMOATE | YYBA CORP | 52a9b5c8-08e6-b91e-e063-6294a90a0e0d | 2026-05-25 | Warnings | M024 |
| PREPAKU FENBENDAZOLE Canine Dewormer | FENBENDAZOLE | Shenzhen Zhenshangzekai Technology Co., Ltd. | 4d722051-6a49-75ea-e063-6294a90a7b4e | 2026-03-20 | Warnings | M024 |
| pinworm treatment | PYRANTEL PAMOATE | BIONPHARMA INC. | 3cf96d04-e8bc-31af-e063-6294a90a0db8 | 2026-01-23 | Warnings | M024 |
| pinworm treatment | PYRANTEL PAMOATE | AMERISOURCE BERGEN | 4837905f-1037-a319-e063-6294a90aba04 | 2026-01-21 | Warnings | M024 |
| Pyrantel Pamoate | PYRANTEL PAMOATE | Jefferson Labs | e862b337-2991-4b56-8584-fd80dccd725f | 2025-12-19 | Warnings | M024 |
| pinworm treatment | PYRANTEL PAMOATE | STRATEGIC SOURCING SERVICES | 453c0645-f2b4-aa4a-e063-6294a90af1fb | 2025-12-05 | Warnings | M024 |
| Lombrix | PYRANTEL PAMOATE | OPMX LLC | 3f940481-8e75-0bc7-e063-6394a90af1cd | 2025-09-24 | Warnings | M024 |
| PARASITOL | PYRANTEL PAMOATE | Menper Distributors Inc. | cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc6 | 2025-07-22 | Warnings | M024 |
| Bismutina | BISMUTH SUBSALICYLATE | Menper Distributors, Inc. | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 2025-07-22 | Warnings | M024 53145-475 |
| PINRID | PYRANTEL PAMOATE | YYBA CORP | fc225b5b-0ce8-4394-a643-39dbc674d7cd | 2025-07-02 | Warnings | M024 |
| MebendamaX Pinworm | PYRANTEL PAMOATE | Pharmadel LLC | 1d75b912-3550-7d4c-e063-6294a90ad5fa | 2025-06-18 | Warnings | M024 |
| Pyrantel Pamoate | PYRANTEL PAMOATE | ProMex LLC | e68c503a-6f79-4f83-a6f3-c12a13fb06a0 | 2024-12-18 | Warnings | M024 |
| Pinworm Medicine | PYRANTEL PAMOATE | REESE PHARMACEUTICAL CO. | f23d5092-48ca-46c4-830a-c34d0a3a7f57 | 2024-12-18 | Warnings | M024 |
| Walgreens Pinworm Medicine | PYRANTEL PAMOATE | Walgreens | 7fd58448-6846-4d8e-994c-d0ca2fd38e68 | 2024-12-18 | Warnings | M024 |
| CVS Pinworm Treatment | PYRANTEL PAMOATE | CVS PHARMACY INC | d079008a-c87a-45f2-8775-0e40241761f0 | 2024-12-18 | Warnings | M024 |
| VRMX 500 | PYRANTEL PAMOATE | OPMX LLC | e119cad8-9814-7d5a-e053-2995a90afde5 | 2024-02-06 | Warnings | M024 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | 14bbbdbb-87c8-47a9-9147-7e0f1b75c7b9 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 53145-475-08 | 53145047508 | 240 mL in 1 BOTTLE (53145-475-08) | 240 ml | 2021-04-01 | 0000-00-00 | No | No | Current |